NCT00455728View on ClinicalTrials.gov

A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders

CompletedOBSERVATIONAL

Enrollment

3,690

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Growth Hormone Disorders

Trial Locations (1)

SL1 3XE

Ipsen Central Contact, Slough

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Ipsen

INDUSTRY